Replies to post #3023 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Spideyboy]

Hi Trickshot,

There's not much to say on Cel-Sci. Data Topline data will be out in a couple months. If positive, which I believe it seems so, then given that Cel-Sci is in the buzzword cancer space, and that there hasn't been anything in HNSCC for 60 years, the stock should do very very well. If that happens there will be probably one more dilution soon after the news, which will give them the money they need with lower impact to shareholders and the money they need to shop around for a commercialisation partner.

If the data is that good, I wonder if they will bother with a partner. I mean based on when the trial should have finished and where we are now, you hardly need a sales-force!

It may take them more time to get the logistics set up but the profit taking should be more significant.